297 related articles for article (PubMed ID: 17376487)
1. Clinical outcome measures in multiple sclerosis.
Amato MP; Portaccio E
J Neurol Sci; 2007 Aug; 259(1-2):118-22. PubMed ID: 17376487
[TBL] [Abstract][Full Text] [Related]
2. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
D'Souza M; Kappos L; Czaplinski A
J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
[TBL] [Abstract][Full Text] [Related]
3. Outcome measures in multiple sclerosis clinical trials.
Andersson PB; Goodkin DE
Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of the individual course of disease: the elements of time, heterogeneity and precision.
Daumer M; Neuhaus A; Herbert J; Ebers G
J Neurol Sci; 2009 Dec; 287 Suppl 1():S50-5. PubMed ID: 20106349
[TBL] [Abstract][Full Text] [Related]
5. Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.
van Winsen LM; Kragt JJ; Hoogervorst EL; Polman CH; Uitdehaag BM
Mult Scler; 2010 May; 16(5):604-10. PubMed ID: 20086019
[TBL] [Abstract][Full Text] [Related]
6. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
7. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
Haro H; Maekawa S; Hamada Y
Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
[TBL] [Abstract][Full Text] [Related]
8. Assessing disability progression with the Multiple Sclerosis Functional Composite.
Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of follow-up and evolution of multiple sclerosis].
Couvreur G
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
[TBL] [Abstract][Full Text] [Related]
10. The relation between subjective and objective measures of everyday life activities in persons with multiple sclerosis.
Goverover Y; Kalmar J; Gaudino-Goering E; Shawaryn M; Moore NB; Halper J; DeLuca J
Arch Phys Med Rehabil; 2005 Dec; 86(12):2303-8. PubMed ID: 16344027
[TBL] [Abstract][Full Text] [Related]
11. The reliability and validity of pain interference measures in persons with multiple sclerosis.
Osborne TL; Raichle KA; Jensen MP; Ehde DM; Kraft G
J Pain Symptom Manage; 2006 Sep; 32(3):217-29. PubMed ID: 16939846
[TBL] [Abstract][Full Text] [Related]
12. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Goodin DS
Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of multiple sclerosis: quantification by use of scales].
Izquierdo G; Ruiz-Peña JL
Rev Neurol; 2003 Jan 16-31; 36(2):145-52. PubMed ID: 12589602
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Ontaneda D; LaRocca N; Coetzee T; Rudick R;
Mult Scler; 2012 Aug; 18(8):1074-80. PubMed ID: 22740488
[TBL] [Abstract][Full Text] [Related]
18. Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Karabudak R; Dahdaleh M; Aljumah M; Alroughani R; Alsharoqi IA; AlTahan AM; Bohlega SA; Daif A; Deleu D; Amous A; Inshasi JS; Rieckmann P; Sahraian MA; Yamout BI
Mult Scler Relat Disord; 2015 May; 4(3):192-201. PubMed ID: 26008936
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
[TBL] [Abstract][Full Text] [Related]
20. [Scales for functional assessment in multiple sclerosis].
Prieto-González JM
Rev Neurol; 2000 Jun 16-30; 30(12):1246-52. PubMed ID: 10935259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
